GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2 | multiple interactions | EXP | | 6480464 | CTD | naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein] | PMID:23192364 | Bcl2 | decreases expression | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | naringenin results in decreased expression of BCL2 mRNA | PMID:30153467 PMID:36235125 | Bcl2 | decreases response to substance | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | BCL2 protein results in decreased susceptibility to naringenin | PMID:19124070 | Bcl2 | multiple interactions | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | [naringenin co-treated with bisphenol A] results in increased expression of BCL2 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of BCL2 mRNA; ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein results in decreased susceptibility to naringenin]; naringenin inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein]; naringenin promotes the reaction [Tamoxifen results in decreased expression of BCL2 mRNA] | PMID:19124070 PMID:30153467 PMID:31254498 PMID:36235125 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |